Please login to the form below

Not currently logged in
Email:
Password:

Liptruzet

This page shows the latest Liptruzet news and features for those working in and with pharma, biotech and healthcare.

Merck profit slides as generics continue to bite

Merck profit slides as generics continue to bite

Merck is hoping to re-inject growth into the cholesterol franchise with the ongoing roll-out of Liptruzet (ezetimibe and atorvastatin) in the US.

Latest news

  • Merck & Co wins green light in US for Zetia-Lipitor combo Merck & Co wins green light in US for Zetia-Lipitor combo

    Merck &Co has been awarded marketing approval for Liptruzet, a new combination cholesterol treatment based on Zetia and generic atorvastatin. ... Merck is upfront about the capabilities of the new therapy, indicating in its press release that while the

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics